DCPH
Deciphera Pharmaceuticals LLC
NASDAQ: DCPH · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$25.59
+0.00% today
Updated 2026-04-30
Market cap
$2.21B
P/E ratio
—
P/S ratio
12.65x
EPS (TTM)
$-2.21
Dividend yield
—
52W range
$0 – $0
Volume
0.0M
Deciphera Pharmaceuticals LLC (DCPH) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-13.27M | $-23.09M | $-36.70M | $-86.78M | $-149.30M | $-239.68M | $-240.82M | $-152.86M | $-146.70M |
| Capital expenditures | $142000.00 | $223000.00 | $406000.00 | $1.13M | $4.93M | $5.32M | $5.97M | $841000.00 | $778000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $2.56M | $1.49M | $4.87M | $9.69M | $20.41M | $37.14M | $46.08M | $51.94M | $50.60M |
| Free cash flow | $-13.41M | $-23.31M | $-37.11M | $-87.91M | $-154.23M | $-245.00M | $-246.79M | $-153.70M | $-147.47M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $139.29M | $97.01M | $-173.44M | $15.58M | $-48.83M | $-22.18M | — |